MedTrace Logo

Comparison of Efficacy Of Probiotic Toothpaste and Chlorhexidine Mouthwash To Reduce S.Mutans

NCT03004196 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2016-12-28

No results posted yet for this study

Summary

Orthodontic appliance causes increase in plaque accumulation, especially around brackets, wires and attachments. Advances in orthodontics in recent time have led to improved quality of appliance and treatment procedures ultimately resulting in improvised standard of patient care.

These bacteria metabolize different kind of carbohydrates accumulated around orthodontic appliances and create acidic environment in the oral cavity leading to enamel demineralization around the brackets and white spot lesions.

This study was carried out to evaluate and compare the efficacy of probiotic toothpaste and chlorhexidine mouthwash in patients undergoing orthodontic treatment with individuals who are not using them.

Conditions

  • White Spot Lesion of Tooth
  • Long Term Adverse Effects
  • Caries, Dental
  • Orthodontic Appliance Complication

Interventions

DRUG

Probiotic Toothpaste

G.D Probiotic Toothpaste bacteriocin Lactic Acid Bacteria

DRUG

Dr. Reddy's Clohex

0.20% Chlorhexidine Mouthwash

OTHER

Control Group

No Probiotic toothpaste \& Chlorhexidine Mouthwash

Sponsors & Collaborators

  • Peoples University, Bhanpur, Bhopal

    lead OTHER

Principal Investigators

  • Dr.Chandrika Dubey, MDS · Peoples University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2015-10-31
Completion
2015-10-31

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03004196 on ClinicalTrials.gov